As the holiday season is upon us, we reflect on the milestones achieved and the memories made in 2024. A heartfelt thank you to everyone who made this year unforgettable. 🙏 Here’s to continuing our journey together in 2025! Wishing you a wonderful holiday season and a happy New Year! 🌟 #Grateful #Reflecting #Team #Innovation #Journey #Genio #Nyxoah
About us
Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Our mission is to become a world leading company by offering unique patient-centric neuromodulation solutions, developed by passionate and exceptionally driven people Nyxoah's therapy Genio® offers: - Unparalleled clinical efficacy - Increased patient comfort, therapy compliance and quality of life - Minimally invasive approach, thus streamlining patient flow and reducing surgery related risks - Positive health economics outcomes by reducing the burden of OSA and its comorbidities
- Website
-
http://www.nyxoah.com
External link for Nyxoah
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Mont-Saint-Guibert
- Type
- Public Company
- Founded
- 2009
- Specialties
- Neurostimulation and Obstructive Sleep Apnea (OSA)
Locations
-
Primary
Get directions
rue Edouard Belin, 12
Mont-Saint-Guibert, 1435, BE
Employees at Nyxoah
-
Bruno Onkelinx
Chief Operating Officer at Nyxoah
-
Ashlea Mittelstaedt, CFA
Medtech Strategist | 30+ Years Market Research | Voice of Clinical Customer | Experienced Fundraiser | Medtech Portfolio Management
-
Philippe Bleiman
Co-founder and managing director at Hydrofix | M.Sc. | MBA
-
Loïc Moreau
President & Managing Director International at Nyxoah
Updates
-
At Nyxoah, we’re shaping the future and making a meaningful difference by improving the lives of many OSA patients every day. Together, as one team, we’re driving change! #OneTeam #Nyxoah #Teamworkmakesthedreamwork #Genio #OSA #Innovation #HGNS #Sleep #ENT
🌟 Incredible First Days at Nyxoah! 🌟 What an exhilarating start to my journey with Nyxoah! From day one, I’ve been surrounded by a great team—smart, focused, and driven with a clear vision and purpose. I couldn’t have asked for a warmer welcome. 🙌 But that's just the beginning... I had the privilege of joining Mr. Ryan Chin Taw Cheong at #UCLH for the first-ever cases in the UK using the #Genio system—our ground-breaking Hypoglossal Nerve Stimulator (#HGNS) designed to treat Obstructive Sleep Apnoea (#OSA). 💤 💥 The response has been overwhelming: - The media coverage was beyond anything we could have imagined, with a staggering reach of over 2.2 BILLION people globally! - Skynewsuk.com invited Olivier Taelman, our CEO, for a live interview to discuss the life-changing impact this therapy could have on the 8 million OSA sufferers in the UK. 🎤 And as if that wasn’t enough… I had the pleasure of joining Vik Veer for an in-depth teaching lab in Berlin and then had the chance to observe Dr. Björn Beckedorf in Harburg, where he set a new record for the most #Genio devices implanted in a single day. 🏅 So many "firsts" in such a short time—and I’m just getting started! Next up: Making the Genio system accessible to more UK OSA sufferers and continuing to push boundaries in 2025 and beyond. I’m beyond excited for what’s to come! 🚀 #Nyxoah #Genio #HealthTech #ObstructiveSleepApnoea #Innovation #Healthcare #Leadership #SleepMedicine #MedicalTechnology #FutureOfHealthcare #MedTec #NHS
-
-
#Nyxoah is extremely proud to announce the launch of our #Genio solution in England, marked by the first successful implants performed at University College London Hospitals NHS Foundation Trust by Mr. Ryan Chin Taw Cheong. Congratulations to Mr. Cheong and his team! #OSA #MakeSleepSimple https://lnkd.in/e_phPQRY
UCLH implanted the first two patients in the UK with a small chip under the chin to help manage the airflow as an estimated 8 million adults in the UK are thought to have obstructive sleep apnea. Read Sky's Thomas Moore's full report 👉 https://trib.al/a7JKLDQ
-
A historic milestone for Nyxoah and Asklepios | Asklepios Klinikum Harburg ENT team: three successful #Genio implants in one day—a world first!! 🎉 Nyxoah extends its gratitude to the outstanding ENT team led by Verse, Prof. Dr. Thomas. With the expertise of Dr. Björn Beckedorf and Dr. Andreea Frasin three patients were successfully implanted with the Genio system in just one day! We deeply appreciate this groundbreaking accomplishment. Looking forward to many more milestones together. Warmest wishes for a wonderful Christmas season and a prosperous 2025 to the entire team! #Teamharburg #HNO #Schlafmedizin #Genio #Nyxoah #Teamwork #Asklepios #OSA #Sleepapnea #Neuromodulation #patientcentriccare #ENT #ENTsurgery #Partnership #HGNS
-
-
#Nyxoah was delighted to attend the 36th Annual Healthcare Conference hosted by Piper Sandler in New York. Our CEO, Olivier Taelman and CFO John Landry presented a corporate update on #Nyxoah and our ongoing journey to bring our unique bilateral neurostimulation therapy #Genio to more and more #OSA patients around the globe. #RestfulNights #MakeSleepSimple
-
-
🎉 10,000 Followers – Thank You! 🙌 We are pleased to share that our Nyxoah community has reached 10,000 followers on LinkedIn! This milestone reflects the growing interest in our mission to transform the lives of people with Obstructive Sleep Apnea through innovative health solutions. 💡 Your engagement drives us to continue advancing sleep health technology and delivering meaningful change for OSA patients worldwide. To everyone who has liked, shared, commented, and followed along with us—thank you for being a part of our journey. 🚀 Here’s to continued growth, innovation, and collaboration as we work toward a healthier, better-rested future together. 🛌✨ #Thankyou #OSA #10KFollowers #Innovation #Patientcentriccare #Genio
-
-
Closing out the week with another successful Genio implantation at CHUV | Lausanne university hospital in Switzerland! A big thank you to Dr. Karma Lambercy and the dedicated team at CHUV, along with Proctor Dr. Philipp Schendzielorz from Universitätsklinikum Würzburg for their shared commitment and expertise to advancing treatment options and improving patient outcomes for OSA. 🙏 #Genio #Neuromodulation #HGNS #OSA #Sleepsurgery #ENT #Lausanne #CHUV #Nyxoah #Patientcare #Innovation
-
-
At the Deutsche Börse Cash Market - Deutsches Eigenkapitalforum in Frankfurt, Loïc Moreau, our President International Markets, shared key milestones that mark Nyxoah's incredible journey forward. From advancing critical FDA milestones to laying the groundwork for future commercial activities in the US and successfully raising significant capital, we’re proud to be building momentum for sustainable growth. Loïc also emphasized the vital role #EKF24 plays in connecting with European investors, fostering meaningful dialogues, and strengthening partnerships across borders. We’re excited about what’s ahead and grateful for the opportunity to share our vision with the investment community! 🎥 Watch the full interview here: https://lnkd.in/gB3QDfvB #DeutschesEigenkapitalforum #Nyxoah #Genio #OSA #MedTech #Innovation #Sleepapnea #NYXH #EKF24
EKF 2024: Interview with Loïc Moreau of Nyxoah SA
https://www.youtube.com/
-
A big thank you to all participants at the Deutsche Gesellschaft für Schlafforschung und Schlafmedizin e.V. for a fantastic #DGSM2024 congress in Essen! It was great to engage in meaningful discussions about the #Genio therapy and the ongoing evolution in OSA care. Excited for the next steps in our conversations! 🫶 #thankyou #sleepmedicine #patientcentriccare #collaboration #science #HGNS #DREAM #neuromodulation #teamworkmakesthedreamwork
-
-
Thank you, Finance Avenue - De Tijd / L'Echo for hosting a great event here in Brussels! A productive Saturday full of valuable conversations and networking. #financeavenue #financeavenue2024 #investorrelations #networking #nyxoah #medtech #mediafin
-